# The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RO6889450 in Healthy Volunteers

> **NCT02699372** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 164 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Placebo
- **DRUG:** RO6889450

## Key facts

- **NCT ID:** NCT02699372
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-21
- **Primary completion:** 2017-04-14
- **Final completion:** 2017-04-14
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2017-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02699372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02699372, "The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RO6889450 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02699372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*